As of June 3, 2021, Libya had registered almost 190,000 positive COVID 19 cases and more than 3,000 COVID-19-related deaths. The average of daily new infections was around 300 in early June, down from a peak of around 1,000 in early April. The true spread of the disease in Libya is likely to be higher because of restricted access to testing across the country (the positivity rate was 12 percent in May), as well as limitations in data compilation. In December 2020, the government reported that Libya had signed a contract with the World Health Organization (WHO) for the purchase of 2.8 million doses of the AstraZeneca COVID-19 vaccine at a cost of about to US$9.4 million. Media reports suggest that Libya has so far received 200,000 doses of Russia's Sputnik V vaccine and more than 57,000 AstraZeneca shots through the WHO. The WHO reports that around 240,000 vaccine doses had been administered in the country as of June 1.